期刊文献+

普罗布考和抗氧化维生素不影响体外实验条件下内皮细胞的白细胞粘附 被引量:2

Probucol and Antioxidative Vitamins Showed no Effect on Leukocytes-Endothelial Cells Adhesion in Vitro
下载PDF
导出
摘要 为探讨预防动脉粥样硬化的药物普罗布考、维生素C和维生素E是否抑制内皮细胞表面粘附分子表达和白细胞—内皮细胞的粘附 ,以及这种抑制是否通过影响核因子 -κB的活性来实现的 ,在液体流动小室中进行细胞粘附实验 ;用ELISA方法测定内皮细胞粘附分子E -选择素的表达 ;用电泳迁移率分析测定内皮细胞核因子 -κB的活性。经肿瘤坏死因子α刺激的内皮细胞核因子 -κB活性增加 ,粘附分子E -选择素的表达上调 (是基础水平的 3.5倍 ) ,其表面HL6 0细胞的粘附增加 (是基础水平的 4~ 2 6倍 ) ,而抗氧化剂PDTC使所有这些变化都受到抑制。PDTC浓度为 18μmol L时对粘附分子E -选择素的表达呈最大半抑制 ;PDTC浓度为 5 2 μmol L时对内皮细胞表面HL6 0细胞的粘附呈最大半抑制。普罗布考、维生素C和维生素E对肿瘤坏死因子α诱导的粘附分子表达和HL6 0细胞与内皮细胞的粘附没有作用 ;对核因子 -κB的活性没有影响。临床上常用的这三种抗氧化剂并未影响作为动脉粥样硬化始动机制之一的E -选择素介导的白细胞 -内皮细胞粘附水平。 Aim To investigate whether antioxidants probucol, vitamin E and vitamin C modulate expression of endothelial cell adhesion molecules through regulating NF-κB activation. Methods The adhesion of HL60 cell on endothelial cells was measured with adhesion assay in a flow chamber. The effects of the antioxidative substances probucol, vitamin E and vitamin C on the expression of endothelial cell adhesion molecules were measured with cell-ELISA. The activation of NF-κB in endothelial cells was investigated in a gel shift assay. Results In TNFα-activated HUVEC, an increase in p65 and p50, a significantly increased expression of E-selectin (3.5 times), and a significantly increased HL60 cell adhesion to HUVECs (4~26 times) were detected. PDTC inhibited these increases. The half-maximal inhibition of PDTC on E-selectin expression and adhesion of HL60 to HUVEC induced by TNFα was at 18 μmol/L and 52 μmol/L, respectively. Probucol, vitamin E and vitamin C showed no effect on TNFα-induced E-selectin expression in endothelialcells, no influence on HL60-endothelial cell adhesion as well as the TNFα-induced activation of NF-κB in endothelial cells. Conclusions These antioxidants could not inhibit adhesion molecule expression.
出处 《中国动脉硬化杂志》 CAS CSCD 2001年第2期115-118,共4页 Chinese Journal of Arteriosclerosis
关键词 内皮细胞 粘附分子 抗氧化剂 核转录因子-KB 普罗布考 Endothelium Adhesion Molecules Antioxidants NF-kappa B
  • 相关文献

参考文献12

  • 1[1]Gersh BJ, Braunwald E, Rutherford JD. Chronic coronary artery disease [M]. In: Braunwald E. Heart disease: a textbook of cardiovascular medicine. 5th ed, Philadelphia: Saunders, 1997; 1 289-345
  • 2[2]Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis [J]. Science, 1991, 251: 788-791
  • 3[3]Schreck R, Meier B, Mannel DN, et al. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells [J]. J Exp Med, 1992, 175: 1 181-194
  • 4[4]Grfe M, Auch-Schwelk W, Graf K, et al. Isolation and characterization of macrovascular and microvascular endothelial cells from human hearts [J]. Am J Physiol, 1994, 267: H2 138-148
  • 5[5]Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei [J]. Nucleic Acids Res, 1983, 11: 1 475-489
  • 6[6]Stampfer MJ, Rimm EB. Epidemiologic evidence for vitamin E in prevention of cardiovascular disease [J]. Am J Clin Nutr, 1995, 62: S1 365-369
  • 7[7]Retsky KL, Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein [J]. Biochim Biophys Acta, 1995, 1257: 279-287
  • 8[8]Kita T, Nagano Y, Yokode M, et al. Prevention of atherosclerotic progression in Watanabe rabbits by probucol [J]. Am J Cardiol, 1988, 62: 13B-19B
  • 9[9]Nunes GL, Sgoutas DS, Redden RA, et al. Combination of vitamins C and E alters the response to coronary balloon injury in the pig [J]. Arterioscler Thromb Vasc Biol, 1995, 15: 156-165
  • 10[10]Rodes J, Cote G, Lesperance J, et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol [J]. Circulation, 1998, 97: 429-436

同被引文献28

  • 1Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H, et al.Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty:the Probucol Angioplasty Restenosis Trial.J Am Coll Cardiol, 1997, 30 (4):855-862
  • 2Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P.The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.N Engl J Med, 1995, 332 (8):488-493
  • 3Simon BC, Cunningham LD, Cohen RA.Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery.J Clin Invest, 1990, 86 (1):75-79
  • 4Anderson TJ.Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction.Heart Fail Rev, 2003, 8 (1):71-86
  • 5Andrews TC, Raby K, Barry J, Naimi CL, Allred E, Ganz P, et al.Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease.Circulation, 1997, 95 (2):324-328
  • 6Rubanyi GM.Vascular effects of oxygen-derived free radicals.Free Radic Biol Med, 1988, 4 (2):107-120
  • 7Henry PD, Cabello OA, Chen CH.Hypercholesterolemia and endothelial dysfunction.Curr Opin Lipidol, 1995, 6 (4):190-195
  • 8Naito M, Hayashi T, Iguchi A.New approaches to the prevention of atherosclerosis.Drugs, 1995, 50 (3):440-453
  • 9Diaz MN, Frei B, Vita JA, Keaney JF Jr.Antioxidants and atherosclerotic heart disease.N Engl J Med, 1997, 337 (6):408-416
  • 10Goodwin AT,Amrani M,Gray CC,Jayakumar J,Marchbank AJ,Yacoub MH.Differential effects of endothelin-1 on isolated working rat hearts before and after ischaemia and reperfusion.Clin Sci (Lond),2002,103 (S48):189-193

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部